Latest press releases and corporate announcements from EdgeNewswire ...

BV500: Entered global research collaboration with Shionogi for broad-spectrum non-tuberculous mycobacteria Successful IPO funding operations into 2028 with BV100 Phase 3 read-out by the end of 2027 ...

Good morning, everyone, and welcome to the Abeona Therapeutics Full Year 2025 Results Conference Call. [Operator Instructions] Please note this conference is being recor ...

Thank you, Hilla, and welcome to IceCure Medical Ltd's conference call to review the financial results as of and for the twelve months ended December 31, 2025, and provide an update on recent ...

I’ve been reviewing tax software and services as a freelancer for PCMag since 1993. Along the way, I took on reviews of other types of business and personal finance technology. Prior to that, I had ...

Abeona Therapeutics (NASDAQ:ABEO) executives said the company is seeing growing patient demand for ZEVASKYN, an autologous cell-based gene therapy approved in April 2025 for adults and pediatric ...

Alex Cooper has the ear of 10 million people. Can her new ad agency introduce brands to them without breaking the spell? Alex Cooper was driving a hot pink Jeep through the desert with former Saturday ...

A corruption scandal has erupted within Bolt’s Azerbaijan operations — and it is not a minor compliance breach. The controversy has exposed alleged systemic bribery, selective onboarding, manipulation ...

Social media users alleged a phone recording featured Charlie Kirk's widow scheduling teenage girls for Jeffrey Epstein's sexualized massages.

The embedded training and coaching AI strengthen human-led delivery, especially for complex customer, member and ...

Deep staffing cuts have left the IRS processing millions of returns with far fewer workers, raising concerns about delays.

Incode Technologies, Inc., the global leader in identity security and fraud prevention, today announced that iBeta PAD testing confirmed Incode’s face liveness technology achieves Level 3 Presentation ...